Traduttore automatico - Read this site in another language

domenica 16 giugno 2019

Airbus tests its Network for the Sky on a MRTT aircraft

Press release, 13 june 2019

13 June 2019 – Airbus has successfully completed a flight demonstration of a connected airborne battlespace scenario, centred on a MRTT aircraft. The test was carried out as part of the development of Airbus’ Network for the Sky (NFTS) programme. This follows on from last August’s demonstration in Canada of secure mobile communications using a stratospheric balloon to simulate a HAPS (High Altitude Pseudo Satellite), such as Airbus’ Zephyr UAV (Unmanned Aerial Vehicle).

NFTS combines various technologies - satellite and ground communications, air-to-ground, ground-to-air and air-to-air tactical links, 5G mobile communications and laser connections - in a resilient, unified, secure, highly interoperable, mesh network. Aircraft, UAVs and helicopters currently use networks with limited bandwidth and interoperability, and often little resilience. NFTS will allow them to form an integral part of high-speed military networks.

“This unique demonstration is a significant milestone in realising our vision of secure connectivity, which will enable the future air combat cloud and enhance real time execution of military missions,” said Evert Dudok, Head of Communications, Intelligence & Security at Airbus Defence and Space.

The demonstration scenario simulates the establishment of multi-Mbit/s, wideband communication links between ground forces operatives, a fighter jet, a MRTT, and a combined air operations centre (CAOC) on the ground. Both the operatives and jet fighter had to send video in real time to provide enhanced real-time situational awareness and receive instructions from the CAOC in return.

The operative located in Getafe (Spain) was equipped with a standard handheld radio for NATO forces (ROVER). The fighter was deployed to obtain imagery of the area of interest and act as a communications node between the operative and the MRTT flying at 30,000 feet within a 150 km radius in secure airspace. Communications were thus relayed between the fighter jet and the MRTT, via a wideband LOS (line-of-sight) data link. The MRTT then routed the video along with its own communications via a wideband satellite link to an space teleport near Washington, D.C. The communications flow was then returned to Europe via a terrestrial link to the CAOC.

This complex scenario demonstrates the real-time operation of secure end-to-end communications across different networks and technologies: ground-air tactical link, air-air wideband link between two aircrafts, air-satellite relay and terrestrial networks. This type of configuration, known as a ‘hybrid network’, represents the future of military communications and meets the needs of armed forces to be able to use a wide range of networks while allowing these to be managed dynamically and transparently. The solutions developed by Airbus thus allow secure IP (Internet Protocol) communications to be established, links to be reconfigured in real time and the available bandwidth to be allocated to data links based on operational priorities.

For this demonstration an MRTT aircraft has been equipped with Janus, Airbus’ new tri-band (Ku-Ka-MilKa) satellite antenna, as well as the latest version of the Proteus satellite modem, which is highly resilient against interference and jamming, and Airbus’ aircraft links integration management system (ALIMS).

This exercise paves the way for the development of the core capability for SMART MRTT connectivity, which will allow the MRTT to act as a high-end communication node. Network for the Sky (NFTS) sets the foundation for the connected airborne battlespace, with the objective to offer a full operational capability by 2020. The NFTS programme is part of Airbus’ Future Air Power project and is fully aligned with the development of the European Future Combat Air System (FCAS).

NATO Cooperative Cyber Defence Centre of Excellence grows to 25 members

NATO Cooperative Cyber Defence Centre of Excellence (CCDCOE) celebrates today the accession of four new members – Bulgaria, Denmark, Norway and Romania – with a special flag-raising ceremony at the CCDCOE. This enlargement makes the CCDCOE in Tallinn, Estonia, the biggest among 25 NATO-accredited centres of excellences.

In eleven years, we have grown from seven founding members to the 25-nations-strong cyber defence hub with prominent world-renowned flagships. We are glad to see so many new nations lining up to join our expert community, it shows that in cyber defence, the co-operation among like-minded countries has become inevitable,“ said Col Tarien, director of the multinational interdisciplinary hub of cyber defence expertise.

“The fact that more and more nations are joining up to actively contribute to the advancement of cyber security reflects the need for improved capabilities in the cyber domain. Increased global connectivity and technological development means that we have to be ready for any type of cyber threat and bring our capabilities up to date. Tackling cyber threats that our democracies are facing demand expert knowledge and skills, which are reinforced by close cooperation between Allies and Partners,” said Col Tarien.

The Centre continues to attract new members: Japan, Croatia, Montenegro, Slovenia and Switzerland are in the process of joining the CCDCOE. In addition, Luxembourg and Australia have announced their intention of accession.

Founded in 2008, NATO CCDCOE is a NATO-accredited international military organisation supporting its member nations and NATO with cyber defence expertise in the fields of technology, strategy, operations, and law. The heart of the Centre is a diverse group of experts: researchers, analysts, trainers, educators. The mix of military, government and industry backgrounds enables the Centre to provide a unique 360-degree approach to cyber defence.

NATO CCDCOE is the home of the Tallinn Manual 2.0 on the International Law Applicable to Cyber Operations. The Centre also organises the world’s largest and most complex international technical cyber defence exercise Locked Shields. Annual Conference on Cyber Conflict CyCon, organized by CCDCOE, brings regularly together more than 600 experts.
The Centre is staffed and financed by its sponsoring nations and contributing participants, altogether 25 countries as of today. Belgium, Bulgaria, the Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Spain, Turkey, the United Kingdom and the United States are signed up as Sponsoring Nations of NATO CCDCOE. Austria, Finland and Sweden are Contributing Participants, a status eligible for non-NATO nations.

Il NATO Cooperative Cyber Defence Centre of Excellence festeggia l'ingresso di quattro nuovi membri

Bulgaria, Danimarca, Norvegia e Romania si uniscono al NATO CCDCOE portando cosi a  il numero dei paesi partecipanti a 25 (dei quali 3 come paesi contributori, status previsto per i paesi non NATO).
La notizia era nell'aria ma è stata ufficializzata il 13 giugno scorso sul sito del CCDCOE. Una cerimonia speciale dell'alzabandiera ha salutato l'avvenimento.
Il direttore del Centro, Colonnello  Jaak Tarien, ha richiamato brevemente la storia del CCDCOE ricordando che in undici anni si è passati dai sette paesi fondatori a 25 paesi dimostrazione che nel settore cyber la collaborazione è diventata inevitabile:

"The fact that more and more nations are joining up to actively contribute to the advancement of cyber security reflects the need for improved capabilities in the cyber domain. Increased global connectivity and technological development means that we have to be ready for any type of cyber threat and bring our capabilities up to date. Tackling cyber threats that our democracies are facing demand expert knowledge and skills, which are reinforced by close cooperation between Allies and Partners”.

Il CCDCOE continua dunque a crescere e ad attirare l'attenzione internazionale. 
Diversi paesi sono attualmente in fase di adesione (Giappone, Croazia, Montenegro, Slovenia e Svizzera) mentre altri hanno dichiarato la propria intenzione di voler aderire (Lussemburgo e Australia).

Il CCDCOE è nato il 14 maggio del 2008 da sette paesi fondatori (Estonia, Germania, Italia, Lettonia, Lituania, Repubblica Slovacca e Spagna) ed è cresciuto nel tempo, anche grazie alla crescente consapevolezza internazionale riguardo i rischi cyber del mondo attuale.

Alessandro RUGOLO

Per approfondire:


sabato 15 giugno 2019

SANS Network Security 2019 Training Event Features More than 45 Courses to Develop Real-World Cyber Security Skills

Press release, Bethesda, MD,  June 3, 2019

SANS Institute, the global leader in cyber security training and certifications, today announced the agenda for one of its largest training events, SANS Network Security 2019 (#SANSNetworkSecurity) taking place September 9-16 in Las Vegas, NV. The event features comprehensive and engaging courses, offering hands-on training with actionable information students can implement immediately upon returning to work.
“The real-world, practical examples paired with an instructor who clearly knew the subject matter inside and out made this training invaluable.”
- Theresa Hanks, Booz Allen Hamilton
Protect your business and advance your career at SANS Network Security 2019 with more than 45 hands-on, immersion-style courses taught by real-world practitioners.
In SANS courses, students are immersed in hands-on lab exercises designed to help them practice, hone, and perfect what they’ve learned. Courses are constantly updated and rewritten to ensure the tools and techniques taught remain current, and on the cutting edge. Students are encouraged to browse all 45+ courses to see what training opportunities exist.
SANS Network Security 2019 offers courses and certifications in the following and more:
  • Cyber Defense
  • Penetration Testing
  • Ethical Hacking
  • Digital Forensics
  • Security Management
  • Incident Response
  • ICS/SCADA Security
  • Cloud Security
  • Critical Security Controls
  • Cyber Threat Intelligence
  • Secure Development
“SANS training is like a high intensity, action packed, thriller movie! So much coming at you but you get to just soak it all in. Exceptional content, tools, and instructors that nurture learning through hands-on help, questions, and lecture.”
- Ryan Baisley, Ogletree Deakins
SANS has an esteemed faculty of cyber security practitioners and course authors. All SANS instructors are active security practitioners, bringing their extensive knowledge and real-world experiences directly to the classroom. They are called on regularly to share their expertise with government and commercial organizations around the world. Meet the SANS faculty teaching at SANS Network Security 2019.
For a complete schedule of courses, NetWars, and evening talks or to register for SANS Network Security 2019, visit:

IBM, KPMG, Merck and Walmart to collaborate as part of FDA's program to evaluate the use of blockchain to protect pharmaceutical product integrity The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products

Press release

ARMONK, N.Y., NEW YORK, KENILWORTH, N.J., and BENTONVILLE, Ark., June 13, 2019 /PRNewswire/ -- IBM (NYSE: IBM), KPMG, Merck (NYSE: MRK), and Walmart (NYSE: WMT) today announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the U.S. Drug Supply Chain Security Act (DSCSA) that addresses requirements to identify, track and trace prescription medicines and vaccines distributed within the United States.

The program is intended to assist drug supply chain stakeholders, including FDA, in developing the electronic, interoperable system that will identify and trace certain prescription drugs as they are distributed within the United States.
"Our supply chain strategy, planning and logistics are built around the customers and patients we serve," said Craig Kennedy, Senior Vice President, Supply Chain, at Merck, which is known as MSD outside the U.S. and Canada. "Reliable and verifiable supply helps improve confidence among all the stakeholders—especially patients—while also strengthening the foundation of our business." 
Each company brings unique expertise to the project, which will create a shared permissioned blockchain network that allows real-time monitoring of products. The proposed network is intended to help reduce the time needed to track and trace inventory; allow timely retrieval of reliable distribution information; increase accuracy of data shared among network members; and help determine the integrity of products in the distribution chain, including whether products are kept at the correct temperature.
"With successful Blockchain pilots in pork, mangoes and leafy greens that provide enhanced traceability, we are looking forward to the same success and transparency in the biopharmaceutical supply chain," said Karim Bennis, Walmart's Vice President of Strategic Planning and Implementation, Health and Wellness. "We believe we have to go further than offering great products that help our customers live better at everyday low prices. Our customers also need to know they can trust us to help ensure products are safe. This pilot and U.S. Drug Supply Chain Security Act requirements will help us do just that."
Blockchain is designed to establish a permanent record and may be integrated with existing supply chain and traceability systems.
"Blockchain could provide an important new approach to further improving trust in the biopharmaceutical supply chain," said Mark Treshock, IBM Global Solutions Leader for Blockchain in Healthcare & Life Sciences. "We believe this is an ideal use for the technology because it can not only provide an audit trail that tracks drugs within the supply chain; it can track who has shared data and with whom, without revealing the data itself. Blockchain has the potential to transform how pharmaceutical data is controlled, managed, shared and acted upon throughout the lifetime history of a drug."
IBM, KPMG, and Walmart, the largest retailer in the U.S., have extensive experience in implementing blockchain solutions to help enhance the safety and traceability of products. Increasingly, customers are requesting more detailed information about products.
"Blockchain's innate ability within a private, permissioned network to provide an 'immutable record' makes it a logical tool to deploy to help address DSCSA compliance requirements," said Arun Ghosh, KPMG Blockchain Leader. "The ability to leverage existing cloud infrastructure is making enterprise blockchain increasingly affordable and adaptable, helping drug manufacturers, distributors and dispensers meet their patient safety and supply chain integrity goals."
The pilot project is scheduled to be completed in fourth quarter of 2019, and results are expected to be published in an FDA DSCSA program report. At that time, the project's participants will evaluate next steps.
About the DSCSA pilot programDSCSA was enacted by Congress on Nov. 27, 2013. It outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. The DSCSA pilot project program is intended to help identify and evaluate the most efficient processes to comply with and apply drug supply chain security requirements. The program will aid in identifying attributes the system will need for enhanced product tracing and verification, as well as electronic means to share the information. The FDA will be sharing new approaches considered through this program with the broader drug supply chain community on the agency's website. Our goal is to ensure that all parties can be apprised of the program's progress and take advantage of any shared learning.
About IBM BlockchainIBM is recognized as the leading enterprise blockchain provider. The company's research, technical and business experts have broken barriers in transaction processing speeds, developed the most advanced cryptography to secure transactions, and are contributing millions of lines of open source code to advance blockchain for businesses. Since 2016, IBM has worked with hundreds of clients across financial services, supply chain, government, retail, digital rights management and healthcare to implement blockchain applications, and operates a number of networks running live and in production. The cloud-based IBM Blockchain Platform delivers the end-to-end capabilities that clients need to quickly activate and successfully develop, operate, govern and secure their own business networks. IBM is an early member of Hyperledger, an open source collaborative effort created to advance cross-industry blockchain technologies. For more information about IBM Blockchain, visit or follow us on Twitter at @ibmblockchain.
About KPMGKPMG LLP is the independent U.S. member firm of KPMG International Cooperative ("KPMG International"). KPMG International's independent member firms have 207,000 professionals in 153 countries and territories. Learn more at The KPMG and IBM Alliance brings together IBM's technology and KPMG's advisory and tax services, combining in-depth industry knowledge of key business issues to deliver innovative solutions for clients. Visit the KPMG and IBM alliance website for more information. Some or all of the services described herein may not be permissible for KPMG audit clients and their affiliates or related entities.
About MerckFor more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.
About WalmartWalmart Inc. (NYSE: WMT) helps people around the world save money and live better - anytime and anywhere - in retail stores, online, and through their mobile devices. Each week, over 275 million customers and members visit our more than 11,300 stores under 58 banners in 27 countries and eCommerce websites. With fiscal year 2019 revenue of $514.4 billion, Walmart employs more than 2.2 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting, on Facebook at  and on Twitter at
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USAThis news release of Merck & Co., Inc., Kenilworth, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company's management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company's 2018 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (